{
    "nctId": "NCT00902330",
    "briefTitle": "Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer",
    "officialTitle": "Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Anxiety Disorder, Breast Cancer, Depression, Fatigue, Pain, Sleep Disorders",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 161,
    "primaryOutcomeMeasure": "Effects of CES as Compared to Sham CES on Symptoms of Depression, Anxiety, Fatigue, Pain and Sleep Disturbances in Women Receiving Adjuvant Chemotherapy for Early-stage Breast Cancer",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of stage I-IIIA breast cancer\n* Scheduled to receive adjuvant chemotherapy\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Pre, peri, or post-menopausal\n* ECOG performance status 0-1\n* No dementia\n* No active psychosis\n* No history of seizure disorder\n* No implanted electrical device\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No prior chemotherapy\n* No initiation of a medication regimen for depression or other psychiatric condition within the past 30 days",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}